Imaging technologies company Digirad Corp.(NSDQ:DRAD) acquired out-sourced cardiac monitoring services provider Telerhythmics in a deal worth up to $4.1 million.
Digirad Corp.
Digirad downscales, outsources manufacturing
Imaging systems maker Digirad Corp.(NSDQ:DRAD) announced this week that it’s shifting its headquarters to Georgia and scaling down its manufacturing in attempts to save some cash and streamline its operations.
Digirad sells imaging technology to Novadaq for $2 million
Digirad Corp.(NSDQ:DRAD) handed over several on-the-shelf and in-development devices to Novadaq (TSE:NDQ) in a $2 million deal that includes 5 pending patent applications and the rights to 13 existing technologies.
ConvaTec names an acting CFO after former finance head splits | Personnel Moves
ConvaTec named John Cannon acting CFO following the departure of Edward Borkowski, who left the company for undisclosed reasons. Cannon moved up the ranks from his former position as VP of finance for the company’s global operations.
Before ConvaTec, Cannon worked in banking at PMC Treasury, Singer Sewing and Bankers Trust/Deutsche Bank.
Abbott, Boston Scientific pay almost no taxes in Ireland despite billions in profits | Wall Street Beat
Covidien restates Q2 financials ahead of pharma spinout | Wall Street Beat
Covidien (NYSE:COV) re-stated its financial results for the fiscal 3rd quarter ended March 29, in anticipation of the planned spinout of its Mallinckrodt pharmaceuticals business next month.
Covidien said the new numbers reflect the pharma unit as a discontinued operation, with COV shareholders slated to receive a tax-free distribution, according to a regulatory filing.
Digirad plans executive shuffle, layoffs and restructuring for diagnostic imaging
Diagnostics imaging devices maker Digirad Corp.(NSDQ:DRAD) announced some big changes for its primary business, as well as an executive shift and a number of layoffs.
Former Boston Scientific VP joins InspireMD board | Personnel Moves
Analysts differ on Abbott’s post-split prospects | Wall Street Beat
Wall Street analysts are by and large predicting good things for Abbott (NYSE:ABT) after it spins out its branded pharmaceuticals division, to be named AbbVie, early next year.
But, although some are decidedly bullish on ABT, others are taking a more cautious approach until more is known about the structure of the deal.
Imaging devices maker Digirad names new CFO | Personnel Moves
Greatbatch proposes to mostly exit Switzerland for Indiana, Mexico | Wall Street Beat
Greatbatch (NYSE:GB) said it wants to largely shutter a pair of plants in Switzerland and relocate their operations to Ft. Wayne, Ind., and Tijuana, Mexico.